Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006170 · ClinicalTrials.gov registry record · Phase 4
Bupropion and Weight Control for Smoking Cessation - 1
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 349
- Enrollment target
NCT00006170 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 349 participants.
The verdict
NCT00006170, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 349 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco abstinence in women.
Interventions
- DRUG Placebo
- DRUG Bupropion
- BEHAVIORAL smoking cessation intervention
- BEHAVIORAL weight concerns intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 349 participants |
| Start Date | 2000-09 |
| Est. Completion | 2010-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006170
The ClinicalTrials.gov registry entry for NCT00006170 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 349 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00006170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006170 about?
NCT00006170 is a clinical study titled "Bupropion and Weight Control for Smoking Cessation - 1". The purpose of this study is to determine whether the addition of bupropion (Zyban) to cognitive behavioral therapy (CBT) will enhance longer-term tobacco abstinence in women.
What is the current status of trial NCT00006170?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 349 participants. The study started on 2000-09. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00006170?
The interventions under investigation include: Placebo (DRUG), Bupropion (DRUG), smoking cessation intervention (BEHAVIORAL), weight concerns intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00006170?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.